• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

真菌失调可预测小儿克罗恩病的诊断。

Fungal dysbiosis predicts the diagnosis of pediatric Crohn's disease.

机构信息

Department of Pediatrics, King Saud University, Riyadh 11461, Saudi Arabia.

Bioinformatics Program, Boston University, Boston, MA 02215, United States.

出版信息

World J Gastroenterol. 2018 Oct 21;24(39):4510-4516. doi: 10.3748/wjg.v24.i39.4510.

DOI:10.3748/wjg.v24.i39.4510
PMID:30356965
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6196340/
Abstract

AIM

To investigate the accuracy of fungal dysbiosis in mucosa and stool for predicting the diagnosis of Crohn's disease (CD).

METHODS

Children were prospectively enrolled in two medical centers: one university hospital and one private gastroenterology clinic in the city of Riyadh, Kingdom of Saudi Arabia. The children with confirmed diagnosis of CD by standard guidelines were considered cases, and the others were considered non-inflammatory bowel disease controls. Mucosal and stool samples were sequenced utilizing Illumina MiSeq chemistry following the manufacturer's protocols, and abundance and diversity of fungal taxa in mucosa and stool were analyzed. Sparse logistic regression was used to predict the diagnosis of CD. The accuracy of the classifier was tested by computing the receiver operating characteristic curves with 5-fold stratified cross-validation under 100 permutations of the training data partition and the mean area under the curve (AUC) was calculated.

RESULTS

All the children were Saudi nationals. There were 15 children with CD and 20 controls. The mean age was 13.9 (range: 6.7-17.8) years for CD children and 13.9 (3.25-18.6) years for controls, and 10/15 (67%) of the CD and 13/20 (65%) of the control subjects were boys. CD locations at diagnosis were ileal (L1) in 4 and colonic (L3) in 11 children, while CD behavior was non-stricturing and non-penetrating (B1) in 12 and stricturing (B2) in 3 children. The mean AUC for the fungal dysbiosis classifier was significantly higher in stools (AUC = 0.85 ± 0.057) than in mucosa (AUC = 0.71 ± 0.067) ( < 0.001). Most fungal species were significantly more depleted in stools than mucosal samples, except for and , which were significantly more abundant. Diversity was significantly more reduced in stools than in mucosa.

CONCLUSION

We found high AUC of fungal dysbiosis in fecal samples of children with CD, suggesting high accuracy in predicting diagnosis of CD.

摘要

目的

探讨黏膜和粪便真菌失调预测克罗恩病(CD)诊断的准确性。

方法

在沙特阿拉伯利雅得市的两家医疗中心(一家大学医院和一家私立胃肠病诊所)前瞻性招募儿童。根据标准指南确诊为 CD 的患儿被视为病例,其余患儿被视为非炎症性肠病对照。根据制造商的方案,利用 Illumina MiSeq 化学对黏膜和粪便样本进行测序,并分析黏膜和粪便中真菌分类群的丰度和多样性。稀疏逻辑回归用于预测 CD 的诊断。通过计算 100 次训练数据分区随机划分的接收器操作特征曲线和平均曲线下面积(AUC)来测试分类器的准确性。

结果

所有患儿均为沙特国民。有 15 例 CD 患儿和 20 例对照。CD 患儿的平均年龄为 13.9 岁(范围:6.7-17.8),对照组为 13.9 岁(3.25-18.6),10/15 例(67%)的 CD 患儿和 13/20 例(65%)的对照组患儿为男孩。诊断时 CD 的部位为回肠(L1)4 例,结肠(L3)11 例,CD 行为为非狭窄非穿透(B1)12 例,狭窄(B2)3 例。粪便真菌失调分类器的平均 AUC 显著高于黏膜(AUC=0.85±0.057 比 0.71±0.067,<0.001)。与黏膜样本相比,粪便中大多数真菌物种明显减少,除外和,它们明显更丰富。多样性在粪便中比在黏膜中显著降低。

结论

我们发现 CD 患儿粪便中真菌失调的 AUC 较高,提示其对 CD 诊断的预测准确性较高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f255/6196340/9d3127b615fd/WJG-24-4510-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f255/6196340/98e5565af285/WJG-24-4510-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f255/6196340/422c811b1637/WJG-24-4510-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f255/6196340/9d3127b615fd/WJG-24-4510-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f255/6196340/98e5565af285/WJG-24-4510-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f255/6196340/422c811b1637/WJG-24-4510-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f255/6196340/9d3127b615fd/WJG-24-4510-g003.jpg

相似文献

1
Fungal dysbiosis predicts the diagnosis of pediatric Crohn's disease.真菌失调可预测小儿克罗恩病的诊断。
World J Gastroenterol. 2018 Oct 21;24(39):4510-4516. doi: 10.3748/wjg.v24.i39.4510.
2
Bacterial dysbiosis predicts the diagnosis of Crohn's disease in Saudi children.肠道菌群失调可预测沙特儿童克罗恩病的诊断。
Saudi J Gastroenterol. 2021 May-Jun;27(3):144-148. doi: 10.4103/sjg.SJG_409_20.
3
Fungal Microbiota Profile in Newly Diagnosed Treatment-naïve Children with Crohn's Disease.新诊断的未经治疗的克罗恩病患儿的真菌微生物群概况
J Crohns Colitis. 2017 May 1;11(5):586-592. doi: 10.1093/ecco-jcc/jjw197.
4
Fungal Dysbiosis in Mucosa-associated Microbiota of Crohn's Disease Patients.克罗恩病患者黏膜相关微生物群中的真菌失调
J Crohns Colitis. 2016 Mar;10(3):296-305. doi: 10.1093/ecco-jcc/jjv209. Epub 2015 Nov 15.
5
Dysbiosis of gut fungal microbiota is associated with mucosal inflammation in Crohn's disease.肠道真菌微生物群失调与克罗恩病的黏膜炎症相关。
J Clin Gastroenterol. 2014 Jul;48(6):513-23. doi: 10.1097/MCG.0000000000000035.
6
Fecal microbial dysbiosis in Chinese patients with inflammatory bowel disease.中国炎症性肠病患者的粪便微生物失调。
World J Gastroenterol. 2018 Apr 7;24(13):1464-1477. doi: 10.3748/wjg.v24.i13.1464.
7
Dysbiosis, inflammation, and response to treatment: a longitudinal study of pediatric subjects with newly diagnosed inflammatory bowel disease.肠道菌群失调、炎症与治疗反应:一项针对新诊断的炎症性肠病儿科患者的纵向研究。
Genome Med. 2016 Jul 13;8(1):75. doi: 10.1186/s13073-016-0331-y.
8
Modulation of faecal metagenome in Crohn's disease: Role of microRNAs as biomarkers.克罗恩病粪便宏基因组的调控:miRNAs 作为生物标志物的作用。
World J Gastroenterol. 2018 Dec 14;24(46):5223-5233. doi: 10.3748/wjg.v24.i46.5223.
9
Siblings of patients with Crohn's disease exhibit a biologically relevant dysbiosis in mucosal microbial metacommunities.克罗恩病患者的兄弟姐妹表现出黏膜微生物元群落中具有生物学相关性的失调。
Gut. 2016 Jun;65(6):944-53. doi: 10.1136/gutjnl-2014-308896. Epub 2015 Apr 8.
10
Bacteriome and Mycobiome Interactions Underscore Microbial Dysbiosis in Familial Crohn's Disease.细菌群落与真菌群落的相互作用突显了家族性克罗恩病中的微生物生态失调。
mBio. 2016 Sep 20;7(5):e01250-16. doi: 10.1128/mBio.01250-16.

引用本文的文献

1
's Exopolysaccharide Mitigates DSS-Induced Colitis Through Dectin-1-Mediated Immunomodulation and Microbiota Remodeling.[某物质]的胞外多糖通过Dectin-1介导的免疫调节和微生物群重塑减轻右旋糖酐硫酸钠诱导的结肠炎 。
Pharmaceuticals (Basel). 2025 Jul 22;18(8):1085. doi: 10.3390/ph18081085.
2
Artificial intelligence use for precision medicine in inflammatory bowel disease: a systematic review.人工智能在炎症性肠病精准医学中的应用:一项系统综述。
Am J Transl Res. 2025 Jan 15;17(1):28-46. doi: 10.62347/XILL3707. eCollection 2025.
3
Fungal dysbiosis following antibacterial monotherapy in canine otitis externa.

本文引用的文献

1
The gut mycobiome of the Human Microbiome Project healthy cohort.人类微生物组计划健康队列的肠道共生真菌组。
Microbiome. 2017 Nov 25;5(1):153. doi: 10.1186/s40168-017-0373-4.
2
Fungal Microbiota Profile in Newly Diagnosed Treatment-naïve Children with Crohn's Disease.新诊断的未经治疗的克罗恩病患儿的真菌微生物群概况
J Crohns Colitis. 2017 May 1;11(5):586-592. doi: 10.1093/ecco-jcc/jjw197.
3
Fungal microbiota dysbiosis in IBD.炎症性肠病中的真菌微生物群失调
犬外耳炎抗菌单药治疗后的真菌失调
J Small Anim Pract. 2025 Mar;66(3):149-157. doi: 10.1111/jsap.13801. Epub 2024 Nov 5.
4
Dysbiotic signatures and diagnostic potential of gut microbial markers for inflammatory bowel disease in Korean population.韩国人群中肠道微生物标志物的生态失调特征及其在炎症性肠病中的诊断潜力。
Sci Rep. 2024 Oct 10;14(1):23701. doi: 10.1038/s41598-024-74002-6.
5
A comprehensive guide to assess gut mycobiome and its role in pathogenesis and treatment of inflammatory bowel disease.评估肠道真菌微生物群及其在炎症性肠病发病机制和治疗中作用的综合指南。
Indian J Gastroenterol. 2024 Feb;43(1):112-128. doi: 10.1007/s12664-023-01510-0. Epub 2024 Feb 27.
6
Fecal Fungal Microbiota (Mycobiome) Study as a Potential Tool for Precision Medicine in Inflammatory Bowel Disease.粪便真菌微生物组(真菌组)研究作为炎症性肠病精准医学的潜在工具。
Gut Liver. 2023 Jul 15;17(4):505-515. doi: 10.5009/gnl220537. Epub 2023 Jun 12.
7
Advances in Understanding the Human Gut Microbiota and Its Implication in Pediatric Celiac Disease-A Narrative Review.理解人类肠道微生物组及其对儿科乳糜泻影响的研究进展——叙述性综述。
Nutrients. 2023 May 27;15(11):2499. doi: 10.3390/nu15112499.
8
Oral Fungal Alterations in Patients with COVID-19 and Recovered Patients.口腔真菌感染在 COVID-19 患者和康复患者中的改变。
Adv Sci (Weinh). 2023 Jul;10(19):e2205058. doi: 10.1002/advs.202205058. Epub 2023 Apr 29.
9
Prediction of Prednisolone Dose Correction Using Machine Learning.使用机器学习预测泼尼松龙剂量校正
J Healthc Inform Res. 2023 Feb 15;7(1):84-103. doi: 10.1007/s41666-023-00128-3. eCollection 2023 Mar.
10
The role of gut microbiome in inflammatory bowel disease diagnosis and prognosis.肠道微生物组在炎症性肠病诊断和预后中的作用。
United European Gastroenterol J. 2022 Dec;10(10):1091-1102. doi: 10.1002/ueg2.12338. Epub 2022 Dec 3.
Gut. 2017 Jun;66(6):1039-1048. doi: 10.1136/gutjnl-2015-310746. Epub 2016 Feb 3.
4
Detecting Microbial Dysbiosis Associated with Pediatric Crohn Disease Despite the High Variability of the Gut Microbiota.尽管肠道微生物群高度可变,但仍可检测出与儿童克罗恩病相关的微生物失调。
Cell Rep. 2016 Feb 2;14(4):945-955. doi: 10.1016/j.celrep.2015.12.088. Epub 2016 Jan 21.
5
Fungal Dysbiosis in Mucosa-associated Microbiota of Crohn's Disease Patients.克罗恩病患者黏膜相关微生物群中的真菌失调
J Crohns Colitis. 2016 Mar;10(3):296-305. doi: 10.1093/ecco-jcc/jjv209. Epub 2015 Nov 15.
6
The human gut mycobiome: pitfalls and potentials--a mycologist's perspective.人类肠道真菌微生物组:陷阱与潜力——真菌学家的视角
Mycologia. 2015 Nov-Dec;107(6):1057-73. doi: 10.3852/15-147.
7
Fungal Signature in the Gut Microbiota of Pediatric Patients With Inflammatory Bowel Disease.炎症性肠病儿科患者肠道微生物群中的真菌特征
Inflamm Bowel Dis. 2015 Aug;21(8):1948-56. doi: 10.1097/MIB.0000000000000454.
8
The fungal microbiota of de-novo paediatric inflammatory bowel disease.初发性儿童炎症性肠病的真菌微生物群
Microbes Infect. 2015 Apr;17(4):304-10. doi: 10.1016/j.micinf.2014.12.001. Epub 2014 Dec 15.
9
Defining dysbiosis and its influence on host immunity and disease.定义生态失调及其对宿主免疫和疾病的影响。
Cell Microbiol. 2014 Jul;16(7):1024-33. doi: 10.1111/cmi.12308. Epub 2014 Jun 2.
10
Incidence of pediatric inflammatory bowel disease in Saudi Arabia: a multicenter national study.沙特阿拉伯儿科炎症性肠病的发病率:一项多中心全国性研究。
Inflamm Bowel Dis. 2014 Jun;20(6):1085-90. doi: 10.1097/MIB.0000000000000048.